Afexa, Paladin nutraceuticals news

Paladin disclosed that it has acquired 5.4 million Afexa shares priced at C$0.36-C$0.55. The company now owns about 15.4 million Afexa shares, or about 15% of the nutraceutical company. Paladin said it is "considering options regarding its investment," including acquiring additional shares or making a public offer for further Afexa shares. Afexa said its board is "reviewing the situation." ...